Parkinson's Disease
A progressive neurodegenerative disorder caused by loss of dopaminergic neurons, marked by resting tremor, rigidity, bradykinesia, and postural instability, with associated non-motor symptoms.
Phase 1/2 and later readouts in Parkinson's Disease, in your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
Total attributable cost
$25.4B
$24,439/patient
Drug spend
Not yet sourced
All severities (2017 MEPS-anchored estimate) · US